中药是目前我国唯一拥有知识产权优势的药物,具有核心竞争力和较强市场控制力。当然,控制力的取得在很大程度上取决于我们的技术创新能力,所以我们要把创新能力和知识产权联系起来,和我们的战略目标联系起来,将创新成果法权化——知识产权化,并且将知识产权市场化,实现对市场的控制和利润最大化。我国加入 WTO 后,相当一部分 Chinese medicine is the only drug that has the advantage of intellectual property in China at present, which has core competitiveness and strong market control. Of course, access to control depends very much on our ability to innovate in technology, so we need to link our ability to innovate with our intellectual property and to link our strategic goals to legalize innovations - intellectual property , And market-oriented intellectual property, to achieve market control and maximize profits. After China’s accession to the WTO, a considerable part